2024-03-17 09:00:00 ET
Summary
- Moats and Monopolies focuses on long only, high quality businesses but occasionally likes to dabble in contrarian turnaround stories.
- The Beauty Health Company recently saw a single day 60%+ drop, after botching a new product launch, losing their CEO and refusing to answer analyst questions.
- Marla Beck has been appointed permanent CEO, and she brings a strong track record within the industry from the founding of the Bluemercury cosmetics chain and subsequent sale to Macy's.
- Along with new CFO, Michael Monahan, the company is being transformed with a new singular focus on extracting value from and scaling its core product.
- SKIN is a risky, long term opportunity that may reward those who can hold their nerves through high levels of volatility.
Moats and Monopolies
Here at Moats and Monopolies, we do things a little bit differently. We write exclusively about companies that we own in our publicly shared portfolio , which beat the S&P 500 by nearly 10% in 2023....
Read the full article on Seeking Alpha
For further details see:
The Beauty Health Company: A Turnaround Post Earnings?